Technological Advancement in Cancer Stem Cell Research
- 61 Downloads
Cancer stem cells (CSCs) display a significant role in cancer research, evidenced from past decade studies. Although, with the passage of time, effective cancer therapy has been developed, still up to now, cancer possesses the second highest mortality worldwide. The only defined characteristic for every therapy failure is the presence of cells with self-renewable capacity known as cancer stem cells in the heterogeneous population of tumor. These CSCs provide a tumor resistance against various therapies like chemotherapy and radiotherapy. Thus, to prolong survival time period of cancer patients, it is prerequisite to eliminate CSC population. Thus, to develop novel effective therapeutics against primary tumors, isolation and characterization of CSCs will provide a novel insight to develop cancer therapeutics. Thus, various in vitro and in vivo approaches have been developed to isolate and target CSCs. In this chapter, we will discuss about how researchers have developed various powerful tools to characterize CSCs to develop better therapeutics to target CSCs and thus cancer and also how technology has sprung up to generate advanced preclinical models of human tumors.
Keywords:Cancer stem cells (CSCs) Spheroids Organoids
Conflict of interest: Authors have declared no conflict of interest for this book chapter.
- 20.Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3(12):1337PubMedCrossRefGoogle Scholar
- 24.Mele L, Liccardo D, Tirino V (2018) Evaluation and isolation of cancer stem cells using ALDH activity assay. Cancer stem cells. Springer, New York, pp 43–48Google Scholar
- 29.Gitschier H, Fang Y, Eglen RM (2017) Three-dimensional cell culture: a rapidly emerging technique for drug discovery. Drug Dicov 55Google Scholar
- 33.Ma X-L, Sun Y-F, Wang B-L, Shen M-N, Zhou Y, Chen J-W, Hu B, Gong Z-J, Zhang X, Cao Y, Pan B-S, Zhou J, Fan J, Guo W, Yang X-R (2019) Sphere-forming culture enriches liver cancer stem cells and reveals stearoyl-CoA desaturase 1 as a potential therapeutic target. BMC Cancer 19(1):760PubMedPubMedCentralCrossRefGoogle Scholar
- 43.Schütte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V (2017) Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun 8:14262PubMedPubMedCentralCrossRefGoogle Scholar
- 45.Weeber F, van de Wetering M, Hoogstraat M, Dijkstra KK, Krijgsman O, Kuilman T, Gadellaa-van Hooijdonk CG, van der Velden DL, Peeper DS, Cuppen EP (2015) Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc Natl Acad Sci U S A 112(43):13308–13311PubMedPubMedCentralCrossRefGoogle Scholar